Moderna, Inc. (MRNA): A bull case theory

We came across a bullish thesis on Moderna, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research. In ...

Moderna, Inc. (MRNA): Among the Best Vaccine Stocks to Buy According to Hedge Funds

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Nasdaq

Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know

Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Moderna Gets Bird Flu Shot Funding After HHS Ends Contract

Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups could help fill the void after the Trump administration slashed federal ...
Insider Monkey

Here’s Why Moderna, Inc. (MRNA) Is Among Monday’s Top Losers

We recently compiled a list of the 10 Firms Drop on Bearish Statements, Disappointing Earnings. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the ...
Benzinga.com

Stock Of The Day: Moderna Stock Plunges, Breaking Key Support Levels Following Earnings Report

Moderna, Inc. (NASDAQ:MRNA) shares are getting hit because of a bad earnings report. The Street didn't like the numbers. The shares have broken a support level and may form a new downtrend. This is ...

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine) ...

Moderna (MRNA) share price

Get the live share price of Moderna Inc (MRNA), including intraday charts, historical performance, key financials, and market ...

Moderna, Inc.: Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, MA / ACCESS Newswire / December 17, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced it will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12th at 7:30 p ...
Insider Monkey

Moderna, Inc. (MRNA): Among Billionaire David E. Shaw’s Small-Cap Stock Picks with Huge Upside Potential

We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) ...

Rivian, Sandisk, And Moderna Are Among the Top 10 Large-Cap Gainers Last Week (Dec. 15-Dec. 19): Are the Others in Your Portfolio?

Top large-cap gainers for Dec. 15–19 were led by Rivian, Moderna, and BioMarin, rising on product/software updates, vaccine ...
Bloomberg L.P.

Moderna Vaccine Fails to Stop Virus Tied to Birth Defects

Moderna Inc. said its vaccine to prevent cytomegalovirus, a common cause of birth defects, failed to meet its goal in a late-stage trial, a setback for the company still struggling to move past the ...